Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal tissue metabolism refers to the complex network of biochemical processes that supply energy and essential metabolites to the retina, one of the most metabolically active tissues in the body. The retina’s high metabolic demand is primarily driven by photoreceptors, which require continuous energy for phototransduction and maintenance of their outer segments. The retina relies on a unique metabolic ecosystem involving close interaction with the retinal pigment epithelium (RPE). Glucose is supplied from choroidal blood, passing through Bruch’s membrane and RPE via GLUT1 transporters before reaching retinal cells. Photoreceptors predominantly utilize aerobic glycolysis (the Warburg effect), converting glucose into lactate even in oxygen-rich conditions. The RPE minimizes its own glucose consumption, instead using alternative fuels such as amino acids, lipids, and lactate produced by photoreceptors. This conserves glucose for neural retinal cells. Metabolic dysregulation contributes directly to blinding diseases such as AMD and inherited retinal dystrophies through oxidative stress, impaired nutrient delivery, or altered waste removal mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal Tissue Metabolism.